Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Cancer Research|May 1, 1998
p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alphaM S Sheikh, T F Burns, Y Huang, et al.Cell|November 23, 1992
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasiaM B Kastan, Q Zhan, W S el-Deiry, et al.Cancer Research|November 15, 1994
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agentsS Fan, W S el-Deiry, I Bae, et al.Blood|August 1, 1995
BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agentsA Bedi, J P Barber, G C Bedi, et al.Nature|September 20, 1997
Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1K Somasundaram, H Zhang, Y X Zeng, et al.Cell|November 19, 1993
WAF1, a potential mediator of p53 tumor suppressionW S el-Deiry, T Tokino, V E Velculescu, et al.Cancer Research|July 1, 1995
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissuesW S el-Deiry, T Tokino, T Waldman, et al.International Journal of Oncology|April 14, 2000
Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistanceN Ozören, M J Fisher, K Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2001
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancerM J Fisher, A K Virmani, L Wu, et al.Oncogene|August 6, 1999
The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractM S Sheikh, Y Huang, E A Fernandez-Salas, et al.Pageof 9